Supplement Presents Studies on Importance of Simpler Diagnostics for Infectious Diseases
By LabMedica International staff writers Posted on 07 Dec 2015 |
The Diagnostics Modelling Consortium (DMC) and the Gates Foundation have published a supplement of papers on their latest research outcomes across a range of infectious diseases that affect developing world countries, emphasizing that improved, well-considered field diagnostics could support elimination of multiple diseases. Studies included the use of mathematical modeling to predict impact of new diagnostic tools.
One of the studies, led by researchers from Imperial College London (London, UK), found that wider use of the pulse oximeter (the finger-clip device that measures blood oxygen and pulse) could prevent 148,000 pneumonia deaths in the under-fives in countries where the disease is most prominent. "This is a very simple tool that could have a very big impact," said paper senior author Prof. Azra Ghani, Imperial's School of Public Health and director of the DMC.
Routinely used in hospitals, pulse oximetry is a simple, noninvasive technology that can help diagnose conditions, such as pneumonia, that trigger low oxygen levels. The device is not routinely available in community settings, where pneumonia is often diagnosed via counting the number of breaths per minute, and observing whether a child is sucking their chest under the rib cage, suggesting a struggle to breathe. The researchers argue that pulse oximetry could allow children to be more quickly diagnosed and sent to hospital for life-saving oxygen and antibiotics. However, they caution, improvement also depends on having access to a nearby hospital or medical facility.
In another paper, researchers call for investment to improve diagnostic screening tools for detection of people who are infected but asymptomatic. For example, current tests for malaria, which involve blood finger-prick sampling, can identify only about 50% of carriers, from whom infection can be transmitted further. Detecting a 10-fold lower density of parasites in blood could increase detection rate to over 80%. “Increasing the sensitivity of these tests could improve the prospect of malaria elimination,” said Dr. Hannah Slater, Imperial’s School of Public Health and lead author of one of the malaria papers. With recent investment from the UK government and the Bill and Melinda Gates Foundation it is hoped that malaria could be eradicated in the next 30 years.
Another paper calls for expanded use and improvement of rapid diagnostic tests for Ebola. In the recent outbreak, Ebola testing took 2–7 days, during which patients remained in a holding area where infected and uninfected patients stayed together until their results came in, increasing the risk of contracting Ebola and taking up limited bed capacity. The authors calculated that if rapid tests had been available and used from the start, the scale of the outbreak could have reduced by a third. “The availability of a rapid diagnostic test could have had a dramatic impact on the epidemic and is therefore a priority for future investment, said lead author Dr. Pierre Nouvellet, Imperial’s School of Public Health.
Other papers in the supplement explore similar issues for HIV, TB, or neglected tropical diseases. "Developing effective tests to diagnose disease is critical to guide use of other interventions, such as drugs and vaccines," said Prof. Ghani, “They therefore have the potential to save lives by directing resources to those most in need.”
The supplement was published December 3, 2015, in the journal Nature under contractual agreement with and funding by the Bill and Melinda Gates Foundation and. Content was not written or reviewed by Nature editors.
Related Links:
Imperial College London
Supplement: Infectious disease control and elimination - Modelling the impact of improved diagnostics
One of the studies, led by researchers from Imperial College London (London, UK), found that wider use of the pulse oximeter (the finger-clip device that measures blood oxygen and pulse) could prevent 148,000 pneumonia deaths in the under-fives in countries where the disease is most prominent. "This is a very simple tool that could have a very big impact," said paper senior author Prof. Azra Ghani, Imperial's School of Public Health and director of the DMC.
Routinely used in hospitals, pulse oximetry is a simple, noninvasive technology that can help diagnose conditions, such as pneumonia, that trigger low oxygen levels. The device is not routinely available in community settings, where pneumonia is often diagnosed via counting the number of breaths per minute, and observing whether a child is sucking their chest under the rib cage, suggesting a struggle to breathe. The researchers argue that pulse oximetry could allow children to be more quickly diagnosed and sent to hospital for life-saving oxygen and antibiotics. However, they caution, improvement also depends on having access to a nearby hospital or medical facility.
In another paper, researchers call for investment to improve diagnostic screening tools for detection of people who are infected but asymptomatic. For example, current tests for malaria, which involve blood finger-prick sampling, can identify only about 50% of carriers, from whom infection can be transmitted further. Detecting a 10-fold lower density of parasites in blood could increase detection rate to over 80%. “Increasing the sensitivity of these tests could improve the prospect of malaria elimination,” said Dr. Hannah Slater, Imperial’s School of Public Health and lead author of one of the malaria papers. With recent investment from the UK government and the Bill and Melinda Gates Foundation it is hoped that malaria could be eradicated in the next 30 years.
Another paper calls for expanded use and improvement of rapid diagnostic tests for Ebola. In the recent outbreak, Ebola testing took 2–7 days, during which patients remained in a holding area where infected and uninfected patients stayed together until their results came in, increasing the risk of contracting Ebola and taking up limited bed capacity. The authors calculated that if rapid tests had been available and used from the start, the scale of the outbreak could have reduced by a third. “The availability of a rapid diagnostic test could have had a dramatic impact on the epidemic and is therefore a priority for future investment, said lead author Dr. Pierre Nouvellet, Imperial’s School of Public Health.
Other papers in the supplement explore similar issues for HIV, TB, or neglected tropical diseases. "Developing effective tests to diagnose disease is critical to guide use of other interventions, such as drugs and vaccines," said Prof. Ghani, “They therefore have the potential to save lives by directing resources to those most in need.”
The supplement was published December 3, 2015, in the journal Nature under contractual agreement with and funding by the Bill and Melinda Gates Foundation and. Content was not written or reviewed by Nature editors.
Related Links:
Imperial College London
Supplement: Infectious disease control and elimination - Modelling the impact of improved diagnostics
Latest Microbiology News
- Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
- CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening
- Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read morePathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more